Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

HYDROXYETHYLCELLULOSE CRS (60MG)

HYDROXYETHYLCELLULOSE CRS (60MG)

ND

DISCOVER
LYSOPHOSPHATIDYLCHOLINE FROM SOYA BEAN CRS (200 MG)

LYSOPHOSPHATIDYLCHOLINE FROM SOYA BEAN CRS (200 MG)

ND

DISCOVER
PHOSPHATIDYLETHANOLAMINE FROMSOYA BEAN CRS (200 MG)

PHOSPHATIDYLETHANOLAMINE FROMSOYA BEAN CRS (200 MG)

ND

DISCOVER
N-ACYL- PHOSPHATIDYLETHANOLAMINE FROM SOYA BEAN CRS (40 MG)

N-ACYL- PHOSPHATIDYLETHANOLAMINE FROM SOYA BEAN CRS (40 MG)

ND

DISCOVER
PARACETAMOL IMPURITY K CRS (15 MG)

PARACETAMOL IMPURITY K CRS (15 MG)

ND

DISCOVER
GUAIFENESIN FOR PEAK IDENTIFICATION CRS (10 MG)

GUAIFENESIN FOR PEAK IDENTIFICATION CRS (10 MG)

ND

DISCOVER
PLATYCODON ROOT DRY EXTRACT FOR SYSTEM SUITABILITY HRS (10 M

PLATYCODON ROOT DRY EXTRACT FOR SYSTEM SUITABILITY HRS (10 M

ND

DISCOVER
COLCHICINE FOR SYSTEM SUITABILITY A CRS (10 MG)

COLCHICINE FOR SYSTEM SUITABILITY A CRS (10 MG)

ND

DISCOVER
ALBENDAZOLE IMPURITY MIXTURE CRS (0.003 MG)

ALBENDAZOLE IMPURITY MIXTURE CRS (0.003 MG)

ND

DISCOVER
TEMOZOLOMIDE FOR PEAK IDENTIFICATION CRS (10 MG)

TEMOZOLOMIDE FOR PEAK IDENTIFICATION CRS (10 MG)

ND

DISCOVER
TIGECYCLINE CRS (150 MG)

TIGECYCLINE CRS (150 MG)

ND

DISCOVER
LEVETIRACETAM IMPURITY E CRS (15 MG)

LEVETIRACETAM IMPURITY E CRS (15 MG)

3886-69-9

DISCOVER